KEELEY BASS: Open Payments
NPI 1477221935 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,371 in 66 payments from 20 companies in 2025. Trend: 2023 $1,616 · 2024 $1,056 · 2025 $1,371
Food & beverage: $1,371
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $417 |
| AstraZeneca Pharmaceuticals LP | 7 | $184 |
| PFIZER INC. | 11 | $169 |
| Lilly USA, LLC | 6 | $117 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $105 |
| Axsome Therapeutics, Inc. | 4 | $79 |
| Astellas Pharma US Inc | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $30 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Medtronic, Inc. | 1 | $23 |
Products named: Ozempic, PREVNAR 20, JARDIANCE, AIRSUPRA, Sunosi, KISUNLA, FARXIGA, MOUNJARO.
Industry payments across OK — which companies pay providers there.
